241 related articles for article (PubMed ID: 7511750)
1. Action of KC-399, a newly synthesized potassium channel opener, on mechanical activity and 86Rb efflux in rat aorta.
Tamura K; Suzuki Y; Yoshida S; Nabata H
J Cardiovasc Pharmacol; 1994 Feb; 23(2):220-6. PubMed ID: 7511750
[TBL] [Abstract][Full Text] [Related]
2. 8-(Diethylamino)-octyl-3,4,5-trimethoxybenzoate inhibits cromakalim-induced 86Rb efflux from the rat aorta.
Lodge NJ; Halaka NN
J Pharmacol Exp Ther; 1993 Jun; 265(3):1399-405. PubMed ID: 8510016
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide.
Quast U; Cook NS
J Pharmacol Exp Ther; 1989 Jul; 250(1):261-71. PubMed ID: 2501478
[TBL] [Abstract][Full Text] [Related]
4. Comparison of effects of cromakalim and pinacidil on mechanical activity and 86Rb efflux in dog coronary arteries.
Masuzawa K; Asano M; Matsuda T; Imaizumi Y; Watanabe M
J Pharmacol Exp Ther; 1990 May; 253(2):586-93. PubMed ID: 2160002
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of Ki1769, a novel vasodilator, in isolated rat aorta.
Kashiwabara T; Nakajima T; Kasai H; Nakajima S; Izawa T; Ogawa N
Arch Int Pharmacodyn Ther; 1994; 327(2):175-83. PubMed ID: 7979826
[TBL] [Abstract][Full Text] [Related]
6. Possible involvement of ATP-sensitive K+ channels in the relaxant response of dog middle cerebral artery to cromakalim.
Masuzawa K; Asano M; Matsuda T; Imaizumi Y; Watanabe M
J Pharmacol Exp Ther; 1990 Nov; 255(2):818-25. PubMed ID: 2123008
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic profiles of YM934, a novel potassium channel opener.
Uchida W; Masuda N; Taguchi T; Shibasaki K; Shirai Y; Asano M; Matsumoto Y; Tsuzuki R; Fujikura T; Takenaka T
J Cardiovasc Pharmacol; 1994 Feb; 23(2):180-7. PubMed ID: 7511745
[TBL] [Abstract][Full Text] [Related]
8. Some degree of overlap exists between the K(+)-channels opened by cromakalim and those opened by minoxidil sulphate in rat isolated aorta.
Bray K; Quast U
Naunyn Schmiedebergs Arch Pharmacol; 1991 Sep; 344(3):351-9. PubMed ID: 1961260
[TBL] [Abstract][Full Text] [Related]
9. Alterations by glyburide of effects of BRL 34915 and P 1060 on contraction, 86Rb efflux and the maxi-K+ channel in rat portal vein.
Hu SL; Kim HS; Okolie P; Weiss GB
J Pharmacol Exp Ther; 1990 May; 253(2):771-7. PubMed ID: 2110977
[TBL] [Abstract][Full Text] [Related]
10. Effects of KC 399, a novel ATP-sensitive K+ channel opener, on electrical and mechanical responses in dog tracheal smooth muscle.
Kamei K; Nabata H; Kuriyama H
J Pharmacol Exp Ther; 1994 Jan; 268(1):319-27. PubMed ID: 8301573
[TBL] [Abstract][Full Text] [Related]
11. Effects of putative K+ channel activator BRL-34915 on arterial contraction and 86Rb efflux.
Cox RH
J Pharmacol Exp Ther; 1990 Jan; 252(1):51-9. PubMed ID: 2299602
[TBL] [Abstract][Full Text] [Related]
12. Differences in the K(+)-channels opened by cromakalim, acetylcholine and substance P in rat aorta and porcine coronary artery.
Bray K; Quast U
Br J Pharmacol; 1991 Mar; 102(3):585-94. PubMed ID: 1285396
[TBL] [Abstract][Full Text] [Related]
13. Effects of rubidium on responses to potassium channel openers in rat isolated aorta.
Greenwood IA; Weston AH
Br J Pharmacol; 1993 Aug; 109(4):925-32. PubMed ID: 8401946
[TBL] [Abstract][Full Text] [Related]
14. Evidence that pinacidil may promote the opening of ATP-sensitive K+ channels yet inhibit the opening of Ca2(+)-activated K+ channels in K(+)-contracted canine mesenteric artery.
Masuzawa K; Matsuda T; Asano M
Br J Pharmacol; 1990 May; 100(1):143-9. PubMed ID: 2115387
[TBL] [Abstract][Full Text] [Related]
15. Glyburide-sensitive K+ channels in cultured rat hippocampal neurons: activation by cromakalim and energy-depleting conditions.
Politi DM; Rogawski MA
Mol Pharmacol; 1991 Aug; 40(2):308-15. PubMed ID: 1715018
[TBL] [Abstract][Full Text] [Related]
16. The dualistic mode of action of the vasodilator drug, nicorandil, differentiated by glibenclamide in 86Rb flux studies in rabbit isolated vascular smooth muscle.
Kreye VA; Lenz T; Theiss U
Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan; 343(1):70-5. PubMed ID: 1827659
[TBL] [Abstract][Full Text] [Related]
17. Potassium channel-opening and vasorelaxant profiles of a novel compound YM099 in rat isolated portal vein and rabbit isolated aorta.
Uchida W; Hirano Y; Shirai Y; Taguchi T; Masuda N; Shibasaki K; Hirano S; Matsumoto Y; Tsuzuki R; Yanagisawa I
Arch Int Pharmacodyn Ther; 1994; 327(3):330-43. PubMed ID: 7848015
[TBL] [Abstract][Full Text] [Related]
18. Tedisamil (KC 8857) differentially inhibits the 86Rb+ efflux-stimulating and vasorelaxant properties of cromakalim.
Bray K; Quast U
Eur J Pharmacol; 1991 Jul; 200(1):163-5. PubMed ID: 1769368
[TBL] [Abstract][Full Text] [Related]
19. The effects of the putative potassium channel activator WAY-120,491 on 86Rb efflux from the rabbit aorta.
Lodge NJ; Cohen RB; Havens CN; Colatsky TJ
J Pharmacol Exp Ther; 1991 Feb; 256(2):639-44. PubMed ID: 1899702
[TBL] [Abstract][Full Text] [Related]
20. Binding of the K+ channel opener [3H]P1075 in rat isolated aorta: relationship to functional effects of openers and blockers.
Quast U; Bray KM; Andres H; Manley PW; Baumlin Y; Dosogne J
Mol Pharmacol; 1993 Mar; 43(3):474-81. PubMed ID: 8450836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
